Aug 2, 2023 | 4 Min Read
Accelerates healthcare product engineering lifecycle by 50% while significantly increasing accuracy.
NASHVILLE, Tenn. / BANGALORE, India – August 2, 2023 – Emids, a global leader in technology-led transformation and digital engineering solutions for the healthcare and life sciences industry, has announced the launch of its Generative AI platform, ‘EPulseAI’ by Emids for the Healthcare industry. The platform is targeted at all participants in the healthcare ecosystem in the US—payers, providers, and tech companies, enabling them to drive better outcomes for patients. EPulseAI by Emids accelerates product engineering and enhances productivity across the healthcare product development lifecycle by as much as 50%.
EPulseAI by Emids is a first-of-its-kind platform in the healthcare industry, designed to focus on revolutionizing and simplifying product development. The platform assists clients in streamlining activities from product ideation to rollout. The integration of EPulseAI into the product development process will enable better products that can improve the quality of medical care, enhance patient outcomes, and elevate the customer experience. For example, previously time-consuming tasks that would require several hours of manual effort can now be accomplished in just a few minutes through the new user interface based on Generative AI, resulting in an impressive user experience with human-like interaction. This streamlined approach not only saves time and resources but also paves the way for remarkable advancements in healthcare operations, ultimately benefitting all stakeholders involved.
“AI is redefining the way we process healthcare data to develop treatments, diagnose diseases and even prevent them altogether. We are thrilled to launch EPulseAI by Emids at a time when the healthcare industry is poised for this digital transformation journey with AI at its core.”
Chief Executive Officer at Emids
“The implications of Generative AI in healthcare are truly remarkable. AI is redefining the way we process healthcare data to develop treatments, diagnose diseases and even prevent them altogether. We are thrilled to launch EPulseAI by Emids at a time when the healthcare industry is poised for this digital transformation journey with AI at its core. EPulseAI by Emids is a purpose-built solution that empowers Healthcare enterprises to enhance value-based care leveraging Generative AI capabilities,” said Sean Narayanan, Chief Executive Officer at Emids.
“Along with a combination of Generative AI tools and our proprietary solutions like Emids HealthConnect and CoreLAKETM, EPulseAI helps enterprises design scalable new products with unprecedented efficiencies, build them with a faster speed time to market while ensuring seamless systems connectivity”, he said.
Speaking on the launch, Ram Singampalli, Chief Delivery Officer at Emids said, “With EPulseAI by Emids we will focus on training and upskilling our engineers and digital healthcare technologists worldwide. EPulseAI, built upon Emids’ deep-rooted healthcare domain expertise, is our strategic, ethical, and secure approach to reshaping product creation with the power of Generative AI.”
“Through EPulseAI we are helping our clients uncover the unique potential of Generative AI and adapt to its ways of working specifically for healthcare. Our solutions ensure their readiness for Generative AI adoption, supercharge their product development journey, bridge the gap between data availability and actionable insights”, he added.
Founded in 1999 and based in Nashville, Emids is a leading provider of digital transformation solutions across the healthcare and life sciences ecosystem, providing tailored, cutting-edge solutions and services across digital strategy, design, and engineering to payers, providers, biopharma, medical technology, and healthcare technology firms. Emids designs human-centered digital solutions and experiences, builds scalable platforms and connects disparate systems to enable interoperability, in its singular mission of advancing the future of health. Learn more at www.emids.com.
For media enquiries, please contact:
VP, Marketing and Communications, Emids